Original Investigation

Direct Oral Anticoagulant Levels at Time of Elective Surgery

JAMA Network Open 10.1001/jamanetworkopen.2025.55875

February 04, 2026 at 11:00 AM EST

Read the full article

What proportion of patients have elevated residual direct oral anticoagulant (DOAC) levels before an elective procedure when discontinuing treatment according to a standardized protocol (1 day before moderate bleeding-risk procedures and 2 days before high bleeding-risk procedures, with adjustments based on the patient’s kidney function)?In this cohort study of 257 patients, 7.6% had elevated DOAC levels of 30 ng/mL or higher before the procedure. Among those receiving apixaban, this proportion was higher (13.6%).These results suggest that the standardized interruption protocol is associated with DOAC levels below 30 ng/mL, although the proportion of patients with levels of 30 ng/mL or greater was higher among those receiving apixaban.

Corresponding Author: Eleonora Camilleri, MD, PhD, Department of Clinical Epidemiology, Leiden University Medical Center, C7-Q, Albinusdreef 2, 2333ZA Leiden, PO Box 9600, 2300 RC Leiden, the Netherlands (e.camilleri@lumc.nl).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks